Volume 14 - Issue 5 - May, 2002
News
Teaching Collection
08/01/2008
Bassem Mikhail, MD, Robert J. Brewer, MD, Vivian L. Clark, MD
Bassem Mikhail, MD, Robert J. Brewer...
Coronary artery perforation is a rare but potentially fatal complication of percutaneous coronary interventions.1,2 Most cases are recognized at the time of the procedure. While some are identified as a localized collection of contrast...
Coronary artery perforation is a rare but potentially fatal complication of percutaneous coronary interventions.1,2 Most cases are recognized at the time of the procedure. While some are identified as a localized collection of contrast...
Coronary artery perforation is a...
08/01/2008
Journal of Invasive Cardiology
Teaching Collection
08/01/2008
Carlos Cafri, MD, Harel Gilutz, MD, Sergio Kobal, MD, Georgeta Esanu, MD, Jean Marc Weinstein, MRCP, Akram Abu-ful, MD, Reuben Ilia, MD
Carlos Cafri, MD, Harel Gilutz, MD, ...
Coronary dissection during percutaneous coronary intervention (PCI) occurs frequently and is associated with variable evolution, including the development of acute closure with serious clinical consequences. Stent sealing of the false lumen...
Coronary dissection during percutaneous coronary intervention (PCI) occurs frequently and is associated with variable evolution, including the development of acute closure with serious clinical consequences. Stent sealing of the false lumen...
Coronary dissection during...
08/01/2008
Journal of Invasive Cardiology
Feature
Case Report
08/01/2008
Mitsuru Kagoshima, MD, Chiharu Kobayashi, MD, *Mafumi Owa, MD
Mitsuru Kagoshima, MD, Chiharu Kobay...
Coronary dissection is a well-known complication of coronary interventions; however, proximal progression of the dissection into the aortic root happens rarely.1 The outcome and therapeutic strategy for this iatrogenic complication need to be...
Coronary dissection is a well-known complication of coronary interventions; however, proximal progression of the dissection into the aortic root happens rarely.1 The outcome and therapeutic strategy for this iatrogenic complication need to be...
Coronary dissection is a...
08/01/2008
Journal of Invasive Cardiology
Vascular Disease
08/01/2008
Debabrata Mukherjee, MD, Marco Roffi, MD, Jay S. Yadav, MD
Debabrata Mukherjee, MD, Marco Roffi...
Aneurysms of the carotid arteries is a rare but well described entity. Cervical carotid artery aneurysms can cause cerebral embolism and transient ischemic attacks.1 Surgery, however, is often difficult because of the location and the damaged...
Aneurysms of the carotid arteries is a rare but well described entity. Cervical carotid artery aneurysms can cause cerebral embolism and transient ischemic attacks.1 Surgery, however, is often difficult because of the location and the damaged...
Aneurysms of the carotid...
08/01/2008
Journal of Invasive Cardiology
Column
Editorial
08/01/2008
Humberto Dighero, MD and Pablo Sep√∫lveda, MD
Humberto Dighero, MD and Pablo Sep√∫l...
To the Editor:
We’ve read the editorial comment1 made by Dr. Turi on our study “Percutaneous Mitral Valvotomy: Six Year Follow-up”.2 Although we thank Dr. Turi for his insights, we disagree profoundly with the core of his criticism...
To the Editor:
We’ve read the editorial comment1 made by Dr. Turi on our study “Percutaneous Mitral Valvotomy: Six Year Follow-up”.2 Although we thank Dr. Turi for his insights, we disagree profoundly with the core of his criticism...
To the Editor:
We’ve read the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Johanna Armstrong, PhD, *Julian Gunn, MD, *Nadine Arnold, VN, Nadim Malik, MD, *K.H. Chan, MRCP, **Terry Vick, PhD, **Peter Stratford, PhD, *David C. Cumberland, FACC, Cathy M. Holt, PhD
Johanna Armstrong, PhD, *Julian Gunn...
Coronary stenting is generally associated with lower rates of restenosis than balloon angioplasty.1,2 However, in-stent restenosis (ISR) remains a significant clinical problem.(3) Pharmacological inhibition of ISR has shown potential in...
Coronary stenting is generally associated with lower rates of restenosis than balloon angioplasty.1,2 However, in-stent restenosis (ISR) remains a significant clinical problem.(3) Pharmacological inhibition of ISR has shown potential in...
Coronary stenting is generally...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Lonnie Miller, RCVT, Amit Gupta, MD, Barry D. Bertolet, MD
Lonnie Miller, RCVT, Amit Gupta, MD,...
In recent years, many changes in antithrombotic regimens and therapies in the settings of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) have been realized. These therapies include the use of glycoprotein IIb/IIIa...
In recent years, many changes in antithrombotic regimens and therapies in the settings of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI) have been realized. These therapies include the use of glycoprotein IIb/IIIa...
In recent years, many changes in...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Wiwun Tantibhedhyangkul, MD and J. Lawrence Stafford, MD
Wiwun Tantibhedhyangkul, MD and J. La...
Case Description. A 72-year-old man was admitted to our institution with unstable angina pectoris. In 1980, he underwent single-vessel coronary artery bypass graft surgery (CABG) receiving a saphenous vein bypass graft (SVG) to the left...
Case Description. A 72-year-old man was admitted to our institution with unstable angina pectoris. In 1980, he underwent single-vessel coronary artery bypass graft surgery (CABG) receiving a saphenous vein bypass graft (SVG) to the left...
Case Description. A 72-year-old...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Rami Doukky, MD and James E. Calvin, MD
Rami Doukky, MD and James E. Calvin, ...
In last month’s issue of the Journal, we published Part I of this article. This month’s conclusion focuses on other risk stratification models and tools.
Several major studies have established the benefit of glycoprotein (GP) IIb/IIIa...
In last month’s issue of the Journal, we published Part I of this article. This month’s conclusion focuses on other risk stratification models and tools.
Several major studies have established the benefit of glycoprotein (GP) IIb/IIIa...
In last month’s issue of the...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Ulf Berglund, MD and Arina Richter, MD, PhD
Ulf Berglund, MD and Arina Richter, M...
The benefit of platelet inhibition during percutaneous coronary intervention (PCI) has been known for some time.1 In recent years, the interest has focused on the platelet glycoprotein IIb/IIIa inhibitors, which block the final common pathway...
The benefit of platelet inhibition during percutaneous coronary intervention (PCI) has been known for some time.1 In recent years, the interest has focused on the platelet glycoprotein IIb/IIIa inhibitors, which block the final common pathway...
The benefit of platelet...
08/01/2008
Journal of Invasive Cardiology
